Plenty of companies with great products have turned out to be dud as investments - not that it is relevant to this thread, but the reason MUS turned out to be a dud had nothing to do with their product or ground.
Let's assume for arguments sake that BIT225 is uniquely effective in macrophages. It is still to be shown that this has any relivance in the treatment of HIV and even if does that this will be a commercial success.
BIT Science Discussion, page-119
-
- There are more pages in this discussion • 171 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
